Full Answer
What is patient assistance?
What is the purpose of patient assistance programs?
How much did Amgen pay Kip Burgess?
What is Pfizer Rxpathways?
What is the Pan Foundation?
How many programs does the Partnership for Prescription Assistance offer?
Does patient assistance work with insurance?
See 2 more
Drug Assistance Programs | AAFA.org
Drug Assistance Programs. Many pharmaceutical companies, state programs and nonprofits have drug assistance programs (PAPs) that offer free or low-cost medicines if you don’t have insurance or are underinsured and can’t afford your medicine.
Foundation Basics | Council on Foundations
Frequently asked questions on basic foundation types and formation.
What is patient assistance?
Patient assistance and prescription access programs help patients obtain free or nearly free medicines. These programs come in different forms – some provide subsidies to needy patients, others offer free or discounted products, product coupons, and copayment assistance.
What is the purpose of patient assistance programs?
Researchers at the University of Southern California Schaeffer Center for Health Policy & Economics concluded that patient assistance programs “help patients afford therapies without good alternatives.”
How much did Amgen pay Kip Burgess?
When patient Kip Burgess ran into an insurance barrier at the pharmacy counter, Amgen overnighted him a check for nearly $3,000. Kaiser Health News reports that “Amgen, the maker of Burgess’ arthritis medicine, provides up to $12,000 of copay assistance each year to commercially insured Enbrel patients who need help meeting out-of-pocket expenses, often regardless of the patient’s financial status.”
What is Pfizer Rxpathways?
Pfizer Assistance Programs: Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings.
What is the Pan Foundation?
PAN Foundation: The PAN Foundation offers nearly 70 disease-specific assistance programs to help patients pay for their out-of-pocket costs, such as deductibles, co-pays and coinsurance, travel expenses and health insurance premiums. Click on the names of the funds to see which funds are currently accepting applications, what type of assistance is available and whether you are eligible for a grant based on your type of health insurance coverage and household income.
How many programs does the Partnership for Prescription Assistance offer?
Partnership for Prescription Assistance: The Partnership for Prescription Assistance offers a single point of access for people who qualify to more than 475 public and private patient assistance programs, including nearly 200 programs offered by pharmaceutical companies.
Does patient assistance work with insurance?
Unlike other health care assistance programs, many patient assistance programs help patients with health insurance. More than half of rheumatoid arthritis patients access their treatments with the help of copay coupons, according to Stanford University research.
What should stakeholders do with PAPs?
Stakeholders should also closely monitor federal and state legislative policy developments regarding PAPs, including copayment assistance and product coupons. K&L Gates regularly advises clients on health care fraud and abuse risk mitigation and compliance matters and facilitate stakeholder engagement with Congress and state legislators and HHS.
When did Aegerion Pharmaceuticals settle?
Aegerion Pharmaceuticals, Inc. Settlement. On September 22, 2017 , Aegerion Pharmaceuticals (“Aegerion”) entered into a $28.8 million settlement of a False Claims Act lawsuit with the U.S. Attorney General for the District of Massachusetts.
What is the rescission of advisory opinion 06-04?
Senate Finance Committee regarding the rescission of Advisory Opinion 06-04, including how the OIG came to learn about the misrepresentations that the charity made, and whether the OIG plans to audit or review other PAPs and similar advisory opinions.
What is the OIG opinion on CVC?
In December 2015, the OIG published a Modified Advisory Opinion 06-04, following the OIG’s request that CVC certify compliance with the additional factors outlined in the 2014 Special Advisory Bulletin. The Modified Advisory Opinion stated that CVC had certified compliance to each additional factor, and further that CVC had proposed additional modifications to its current operations. [13] The OIG concluded in the Modified Advisory Opinion 06-04 that CVC’s PAP was sufficiently low risk and the OIG would not impose CMPs or sanctions on CVC under the AKS.
What are the two aspects of PAP?
The OIG has indicated that PAPs generally have two “remunerative aspects” that require scrutiny under the AKS: i) donor contributions , which the OIG stated can be analyzed as indirect remuneration to patients , and ii) financial assistance remuneration provided directly to patients. The OIG states that the AKS could be violated “if a donation is made to a PAP to induce the PAP to recommend or arrange for the purchase of the donor’s federally reimbursable items,” as well as if a PAP’s grant of financial assistance to a patient is made “to influence the patient to purchase (or induce the patient’s physician to prescribe) certain items.” [5]
What is the focus of PAPs?
Ultimately, data sharing and communication between charity PAPs and donors appears to be the key area of focus for OIG, DOJ, and IRS enforcement. If such communication and data sharing is prohibited, whether by state statute or federal regulatory enforcement, it is remains to be seen whether PAPs will continue to operate as they are currently structured. In any event, it is incumbent upon interested parties to stay abreast of changes in the law and developing enforcement trends, and to continually monitor and update their compliance programs accordingly. For example, given the amount of scrutiny applied to coordination between the business and charitable giving arms of medical product manufacturers, compliance programs should be actively examining all intra-firm transactions to assure that no improper influence is being exerted over communications with and donations to charity PAPs.
What is the complaint against PSI?
district court for the Eastern District of Virginia, alleging that the OIG’s recent guidance prohibits PSI’s protected free speech with donors and potential donors, jeopardizing PSI’s ability to operate. [29] .
What is patient assistance?
Patient assistance and prescription access programs help patients obtain free or nearly free medicines. These programs come in different forms – some provide subsidies to needy patients, others offer free or discounted products, product coupons, and copayment assistance.
What is the purpose of patient assistance programs?
Researchers at the University of Southern California Schaeffer Center for Health Policy & Economics concluded that patient assistance programs “help patients afford therapies without good alternatives.”
How much did Amgen pay Kip Burgess?
When patient Kip Burgess ran into an insurance barrier at the pharmacy counter, Amgen overnighted him a check for nearly $3,000. Kaiser Health News reports that “Amgen, the maker of Burgess’ arthritis medicine, provides up to $12,000 of copay assistance each year to commercially insured Enbrel patients who need help meeting out-of-pocket expenses, often regardless of the patient’s financial status.”
What is Pfizer Rxpathways?
Pfizer Assistance Programs: Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings.
What is the Pan Foundation?
PAN Foundation: The PAN Foundation offers nearly 70 disease-specific assistance programs to help patients pay for their out-of-pocket costs, such as deductibles, co-pays and coinsurance, travel expenses and health insurance premiums. Click on the names of the funds to see which funds are currently accepting applications, what type of assistance is available and whether you are eligible for a grant based on your type of health insurance coverage and household income.
How many programs does the Partnership for Prescription Assistance offer?
Partnership for Prescription Assistance: The Partnership for Prescription Assistance offers a single point of access for people who qualify to more than 475 public and private patient assistance programs, including nearly 200 programs offered by pharmaceutical companies.
Does patient assistance work with insurance?
Unlike other health care assistance programs, many patient assistance programs help patients with health insurance. More than half of rheumatoid arthritis patients access their treatments with the help of copay coupons, according to Stanford University research.
